Literature DB >> 8149036

Recent advances in the diagnosis and surgical treatment of patients with carcinoma of the esophagus.

K Sugimachi1, M Watanabe, N Sadanaga, M Ikebe, K Kitamura, M Mori, H Kuwano.   

Abstract

Five hundred and eighty-five patients with carcinoma of the thoracic esophagus underwent resection of the esophagus in the surgical department in which we work since 1965. The postoperative 30 day mortality rate was 11.9 percent during the early period, from 1965 to 1974, whereas it has decreased to 1.3 percent in the period since 1985. The most common cause of mortality was pulmonary complications (45.8 percent). The five year survival rate of patients who underwent a curative resection between 1975 and 1984 was only 29.1 percent, whereas it has remarkably increased to 49.9 percent since 1985, at which time cervical thoracic and abdominal lymph node dissection began to be regularly performed. There were three patients with intraepithelial carcinoma and 17 with mucosal carcinoma, respectively; none of these patients died within five years postoperatively. However, the five year survival rate of 73 patients with submucosal carcinoma of the esophagus was only 52.6 percent. Thus, it is clear that the prognosis substantially worsens when carcinomatous invasion reaches the submucosal layer. From the results of this study, it can be concluded that a combination of early detection and resection of the esophagus with three field lymph node dissection offers the best chance for long term survival in patients with carcinoma of the esophagus.

Entities:  

Mesh:

Year:  1994        PMID: 8149036

Source DB:  PubMed          Journal:  J Am Coll Surg        ISSN: 1072-7515            Impact factor:   6.113


  10 in total

1.  Guidelines for the management of oesophageal and gastric cancer.

Authors:  W H Allum; S M Griffin; A Watson; D Colin-Jones
Journal:  Gut       Date:  2002-06       Impact factor: 23.059

2.  Abdominal incisional hernia occurring after an esophagectomy reconstructed with a gastric tube through an antesternal route: report of a case.

Authors:  H Saeki; H Kuwano; H Kawaguchi; K Sonoda; T Ohga; K Kitamura; H Nakashima; Y Toh; K Sugimachi; T Oiwa
Journal:  Surg Today       Date:  1998       Impact factor: 2.549

3.  Centralisation of oesophagogastric cancer services: can specialist units deliver?

Authors:  M J Forshaw; J A Gossage; J Stephens; D Strauss; A J Botha; S Atkinson; R C Mason
Journal:  Ann R Coll Surg Engl       Date:  2006-10       Impact factor: 1.891

4.  A novel isoform of human fibroblast growth factor 8 is induced by androgens and associated with progression of esophageal carcinoma.

Authors:  S Tanaka; H Ueo; K Mafune; M Mori; J R Wands; K Sugimachi
Journal:  Dig Dis Sci       Date:  2001-05       Impact factor: 3.199

5.  A case of cardiac tamponade following esophageal resection.

Authors:  Yoshiaki Mizuguchi; Shinhiro Takeda; Masao Miyashita; Hiroyuki Ikezaki; Yushi Nakajima; Shinji Akada; Hiroshi Makino; Ryohei Futami; Masao Arai; Koji Sasajima; Takashi Tajiri; Keiji Tanaka
Journal:  J Anesth       Date:  2005       Impact factor: 2.078

6.  A novel variant of human Grb7 is associated with invasive esophageal carcinoma.

Authors:  S Tanaka; M Mori; T Akiyoshi; Y Tanaka; K Mafune; J R Wands; K Sugimachi
Journal:  J Clin Invest       Date:  1998-08-15       Impact factor: 14.808

7.  Elongation factor 1 gamma mRNA expression in oesophageal carcinoma.

Authors:  K Mimori; M Mori; H Inoue; H Ueo; K Mafune; T Akiyoshi; K Sugimachi
Journal:  Gut       Date:  1996-01       Impact factor: 23.059

8.  Expression of pyrimidine nucleoside phosphorylase mRNA plays an important role in the prognosis of patients with oesophageal cancer.

Authors:  M Yamagata; M Mori; K Mimori; K I Mafune; Y Tanaka; H Ueo; T Akiyoshi
Journal:  Br J Cancer       Date:  1999-02       Impact factor: 7.640

9.  A dominant negative mutation of transforming growth factor-beta receptor type II gene in microsatellite stable oesophageal carcinoma.

Authors:  S Tanaka; M Mori; K Mafune; S Ohno; K Sugimachi
Journal:  Br J Cancer       Date:  2000-05       Impact factor: 7.640

10.  A novel frizzled gene identified in human esophageal carcinoma mediates APC/beta-catenin signals.

Authors:  S Tanaka; T Akiyoshi; M Mori; J R Wands; K Sugimachi
Journal:  Proc Natl Acad Sci U S A       Date:  1998-08-18       Impact factor: 11.205

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.